Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Acorda Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- 0 vs. Q4 2021
- Shares held
- 3.37M
- −598.0K (−15.1%) vs. Q4 2021
- Total value
- $5.42M
- −$4.06M (−42.8%) vs. Q4 2021
- New holders
- 4
- 3 more added
- Sold out
- 4
- 10 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 2 | $8.00K |
| Q1 2024 | 17 | $2.13M |
| Q4 2023 | 15 | $2.33M |
| Q3 2023 | 16 | $2.30M |
| Q2 2023 | 15 | $1.94M |
| Q1 2023 | 30 | $3.71M |
| Q4 2022 | 36 | $4.09M |
| Q3 2022 | 36 | $1.91M |
| Q2 2022 | 35 | $3.08M |
| Q1 2022 | 34 | $5.42M |
| Q4 2021 | 34 | $9.48M |
| Q3 2021 | 36 | $14.7M |
| Q2 2021 | 37 | $18.1M |
| Q1 2021 | 37 | $18.0M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Acorda Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 1 | $0 | 0.00% | −30,401−100.0% | Reduced |
| Royal Bank of Canada | 336 | $0 | 0.00% | −559−62.5% | Reduced |
| JPMorgan Chase & Co | 8 | $0 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 50 | $0 | 0.00% | 00.0% | Unchanged |
| IMA Wealth, Inc. | 17 | $0 | 0.00% | 00.0% | Unchanged |
| JNBA Financial Advisors | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 85 | $0 | 0.00% | 00.0% | Unchanged |
| Private Capital Group, LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 37 | $0 | 0.00% | +37 | New |
| Federated Hermes, Inc. | 755 | $1.00K | 0.00% | −98,027−99.2% | Reduced |
| Tower Research Capital LLC (TRC) | 579 | $1.00K | 0.00% | +579 | New |
| Citigroup Inc | 1,658 | $3.00K | 0.00% | +1,658 | New |
| UBS Group AG | 2,815 | $4.00K | 0.00% | +2,798+16,458.8% | Added |
| Morgan Stanley | 4,799 | $8.00K | 0.00% | −262−5.2% | Reduced |
| Simplex Trading, LLC | 5,692 | $9.00K | 0.00% | −3,701−39.4% | Reduced |
| Russell Investments Group, Ltd. | 6,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 13,505 | $22.0K | 0.00% | +13,505 | New |
| Two Sigma Advisers, LP | 14,400 | $23.0K | 0.00% | −2,900−16.8% | Reduced |
| HN Saltoro Capital, LP | 14,848 | $24.0K | 0.03% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 19,752 | $32.0K | 0.00% | −24,745−55.6% | Reduced |
| Susquehanna Fundamental Investments, LLC | 22,600 | $36.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,628 | $43.0K | 0.00% | +510+2.0% | Added |
| United Asset Strategies, Inc. | 27,100 | $44.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 31,648 | $51.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 40,921 | $66.0K | 0.00% | −50,041−55.0% | Reduced |
| Geode Capital Management, LLC | 46,721 | $75.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 49,875 | $80.0K | 0.00% | +10.0% | Added |
| BlackRock Inc. | 165,474 | $266.0K | 0.00% | −1,204−0.7% | Reduced |
| Bridgeway Capital Management, LLC | 244,090 | $393.0K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 341,545 | $549.0K | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 464,276 | $747.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 467,739 | $751.0K | 0.00% | 00.0% | Unchanged |
| Canyon Capital Advisors LLC | 649,031 | $1.04M | 0.04% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 707,218 | $1.14M | 0.00% | −6,938−1.0% | Reduced |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −282,193−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −77,868−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −23,840−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −14,455−100.0% | Sold out |